Your Patients Need Mercaptopurine — Here's How to Help Them Get It

When a patient calls your office saying they can't fill their Mercaptopurine prescription, it creates a cascade of problems: missed doses, anxiety, phone calls back and forth with pharmacies, and — most critically — potential treatment interruptions for conditions like acute lymphoblastic leukemia or inflammatory bowel disease.

The Mercaptopurine shortage has persisted since late 2023, and as of 2026, there's no firm resolution in sight. But there are concrete steps you and your staff can take to help patients maintain access. This guide outlines a practical workflow.

Current Availability: What You Need to Know

A quick snapshot of where things stand:

• Generic Mercaptopurine 50 mg tablets: Available from a limited number of manufacturers but subject to wholesaler allocation limits. Quinn Pharmaceuticals has temporarily discontinued production with no return date.
• Purixan (20 mg/mL oral suspension): Available through specialty pharmacies. Same active ingredient, different formulation. More expensive but generally not affected by the tablet shortage.
• Availability varies by region and pharmacy type. Independent pharmacies and hospital outpatient pharmacies tend to have better access than chain retail pharmacies during shortages.

Why Patients Can't Find Mercaptopurine

Understanding the bottleneck helps you address it effectively:

1. Wholesaler allocation limits: Major distributors (McKesson, Cardinal Health, AmerisourceBergen) restrict order quantities for shortage drugs. A pharmacy may be limited to a few bottles per order cycle, regardless of patient demand.
2. Centralized chain ordering: Chain pharmacies (CVS, Walgreens, Rite Aid) use centralized inventory systems that distribute shortage drugs across thousands of locations, limiting what any single store receives.
3. Limited manufacturer base: With only a handful of companies producing generic Mercaptopurine, any single manufacturer's exit (like Quinn's) has an outsized impact on supply.
4. Patients calling multiple pharmacies: Without a centralized stock-checking tool, patients end up calling 10+ pharmacies, which is time-consuming and often unsuccessful — especially later in the day when stock may already be claimed.

What Providers Can Do: 5 Actionable Steps

Step 1: Verify Stock Before Sending Prescriptions

One of the most common frustrations for patients is receiving a prescription that can't be filled. Before sending a new or refill prescription:

• Have your office staff check pharmacy availability using Medfinder for Providers
• Call the pharmacy directly to confirm current stock
• Ask the pharmacy if they can order Mercaptopurine from their wholesaler — sometimes it's orderable even if not currently on the shelf

This extra step takes a few minutes but saves patients hours of frustration and missed doses.

Step 2: Build Relationships with Specialty Pharmacies

Specialty pharmacies that serve oncology and gastroenterology patients are your best allies during shortages. They often:

• Have dedicated supply agreements with manufacturers
• Maintain larger inventories of niche medications
• Can coordinate insurance authorization more efficiently
• Offer delivery, reducing the patient's logistical burden

Identify 2-3 specialty pharmacies in your area (or nationally, if they ship) and establish referral relationships. Share their contact information with patients proactively.

Step 3: Prescribe Purixan When Tablets Are Unavailable

Purixan (Mercaptopurine oral suspension, 20 mg/mL) is pharmacologically identical to the tablet — same drug, liquid form. When tablets can't be found:

• Write for Purixan by name
• Include a note on the prescription documenting the tablet shortage — this supports prior authorization
• Route the prescription to a specialty pharmacy that stocks Purixan
• Note: Purixan is significantly more expensive ($2,000+/month cash), so insurance coverage is critical

Step 4: Know Your Alternatives

When neither Mercaptopurine tablets nor Purixan are accessible, be ready with alternatives appropriate to the indication:

For IBD (Crohn's/UC):

• Azathioprine (Imuran): Prodrug of Mercaptopurine, widely available. Convert dose: Azathioprine 2–2.5 mg/kg/day ≈ Mercaptopurine 1–1.5 mg/kg/day
• Methotrexate: 15–25 mg/week (subcutaneous preferred). Established alternative immunomodulator

For ALL maintenance:

• Follow institutional protocol for 6-MP interruptions
• Thioguanine may be considered in select cases (limited by hepatotoxicity risk with long-term use)
• Consult with pharmacy about potential compounding options

For autoimmune conditions:

• Azathioprine or Mycophenolate mofetil (CellCept), depending on the condition and patient factors

For a detailed review, see our alternatives to Mercaptopurine article.

Step 5: Connect Patients with Cost and Access Resources

The shortage compounds existing cost barriers for many patients. Direct them to:

• Discount coupons: GoodRx and SingleCare can reduce generic Mercaptopurine from $400+ to as low as $48–$56
• Patient assistance programs: NeedyMeds, RxAssist, PAN Foundation (for cancer), HealthWell Foundation
• Medfinder: medfinder.com for finding pharmacies with stock

A detailed guide you can share with patients: How to save money on Mercaptopurine.

Workflow Tips for Your Practice

Consider integrating these shortage management practices into your clinic workflow:

• Flag shortage medications in your EHR: Add alerts for Mercaptopurine so that any prescriber in the practice is reminded to verify stock before prescribing
• Designate a staff member for shortage management: A pharmacy liaison or nurse who tracks shortage status and maintains pharmacy contacts can save significant time across the practice
• Proactive refill management: For patients on Mercaptopurine maintenance, initiate refill coordination 10–14 days before the supply runs out rather than waiting for the patient to call
• Document everything: Note the shortage in the patient chart when prescribing alternatives or making dosing changes. This supports continuity of care and insurance appeals
• Educate patients: Share Medfinder and relevant blog posts (linked below) so patients have tools to help themselves between appointments

Final Thoughts

Drug shortages are a systemic problem that falls disproportionately on patients — many of whom are already dealing with cancer, chronic illness, or both. As providers, the most impactful thing we can do is be proactive: verify stock, build pharmacy relationships, know alternatives, and equip patients with the tools and information they need.

For provider-specific tools and real-time pharmacy data, visit medfinder.com/providers.

Patient-facing resources to share:

• How to find Mercaptopurine in stock near you
• Mercaptopurine shortage update for patients (2026)
• What is Mercaptopurine?